|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2006.05.5988 on August 22 2006 © 2006 American Society of Clinical Oncology. Allometric Scaling Law Questions the Traditional Mechanical Model for Axillary Lymph Node Involvement in Breast Cancer
From the Departments of Medical Oncology, Medical Statistics and Biometry, and Breast Surgery, Istituto Nazionale Tumori; Medical Statistics and Biometry, Università di Milano, Milano, Italy; The University of South Carolina, Dorn Veteran's Administration Medical Center, Columbia, SC; and the Department of Vascular Biology, Children's Hospital and Harvard Medical School, Boston, MA Address reprint requests to Romano Demicheli, MD, PhD, Istituto Nazionale Tumori di Milano, Via Venezian 1, 20137 Milano, Italy; e-mail: demicheli{at}istitutotumori.mi.it PURPOSE: To find a quantitative relationship between tumor size and frequency of axillary lymph node involvement.
PATIENTS AND METHODS: The frequency of axillary node involvement versus primary tumor volume was analyzed in 10 selected series of patients incorporating a total of 57,244 women with resectable breast cancer. The average number of events per unit volume resulting in tumor spread to axillary lymph nodes before tumor surgical removal
RESULTS: The allometric scaling law CONCLUSION: Results suggest that the phenomenon should be related to some internal structural trait of the tumor. The vascular network seems to be the best candidate. This result does not support a mere mechanical model of lymphatic tumor spread. A more complex biology-based model of lymphohematogenous spread is suggested, in which the axillary nodes draining the lymph from the primary tumor may become activated by factors produced by both tumor cells and tumor stroma, thus favoring cell-selective homing of otherwise circulating tumor cells. The success of fractal features related to the internal architecture brings additional support to the consideration of primary breast cancer as an organ-like structure. published online ahead of print at www.jco.org on August 21, 2006. Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article. This article has been cited by other articles:
|
||||||||||||
|
|||||||||||
|
Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|